Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-02-17

Clinical Trial Update: Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection [Phase 2, Phase 3]

View source ↗

Summary

The trial compares distilled water to mitomycin C for preventing recurrence after transurethral resection of recurrent superficial bladder cancer, spanning Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Distilled water
  • Mitomycin-C (mitomycin C)

Snippet

Sponsor: Bozyaka Training and Research Hospital | Conditions: Recurrent Superficial Bladder Cancer, Distilled Water | Phase 2, Phase 3 | Status: UNKNOWN